Interferon-?-induced increased sensitivity ofHER2/neu-overexpressing tumor cells to lymphokine-activated killer cell lysis: importance of ICAM-1 in binding and post-binding events-Reference-Cited by-同舟云学术

Interferon-?-induced increased sensitivity ofHER2/neu-overexpressing tumor cells to lymphokine-activated killer cell lysis: importance of ICAM-1 in binding and post-binding events

Published:1993-09 Issue:5 Volume:37 Page:329-336
ISSN:0340-7004
Container-title:Cancer Immunology Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Fady Catherine,Gardner Agnes,Gera Joseph F.,Lichtenstein Alan

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/article/10.1007/BF01518456/fulltext.html

Reference26 articles.

1. Bernasconi S, Peri G, Sironi M, Mantovani A (1991) Involvement of leukocyte (?2) integrins (CD18/CD11) in human monocyte tumoricidal activity. Int J Cancer 49: 267

2. Blanchard DK, Hall RE, Djeu JY (1990) Role of CD18 in lymphokine activated killer (LAK) cell-mediated lysis of human monocytes: comparison with other LAK targets. Int J Cancer 45: 312

3. De Fries RU, Golub SH (1988) Characteristics and mechanism of IFN-? induced protection of human tumor cells from lysis by lymphokine-activated killer cells. J Immunol 140: 3686

4. Fady C, Gardner AM, Gera JF, Lichtenstein A (1992) Interferon-induced increase in sensitivity of ovarian cancer targets to lysis by lymphokine-activated killer cells: selective effects on HER2/neu-over-expressing cells. Cancer Res 52: 764

5. Fady C, Gardner AM, Gera JF, Lichtenstein A (1993) Resistance ofHER2/neu-overexpressing tumor targets to lymphokine activated killer cell mediated lysis: evidence for deficiency of binding and post-binding events. Cancer Immunol Immunother 36: 307

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IFNγ-Induced Bcl3, PD-L1 and IL-8 Signaling in Ovarian Cancer: Mechanisms and Clinical Significance;Cancers;2024-07-27

2. A T cell receptor associated with naturally occurring human tumor immunity;Proceedings of the National Academy of Sciences;2007-11-19

3. Highly efficient redirected anti-tumor activity of human lymphocytes transduced with a completely human chimeric immune receptor;The Journal of Gene Medicine;2005

4. Interleukin-2 enhances the natural killer cell response to Herceptin-coated Her2 /neu-positive breast cancer cells;European Journal of Immunology;2001-10

5. Natural killer cell cytotoxicity of breast cancer targets is enhanced by two distinct mechanisms of antibody-dependent cellular cytotoxicity against LFA-3 and HER2/neu;Experimental Hematology;1999-10